David L Sexton, MSW ACSW LCSW DCSW L | |
505 Silhavy Rd, Ste 100, Valparaiso, IN 46383-4461 | |
(219) 464-1234 | |
(219) 464-1235 |
Full Name | David L Sexton |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 505 Silhavy Rd, Valparaiso, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518915644 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 34000094 (Indiana) | Secondary |
1041C0700X | Social Worker - Clinical | 34000246 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
David L Sexton, MSW ACSW LCSW DCSW L 505 Silhavy Rd, Ste 100, Valparaiso, IN 46383-4461 Ph: (219) 464-1234 | David L Sexton, MSW ACSW LCSW DCSW L 505 Silhavy Rd, Ste 100, Valparaiso, IN 46383-4461 Ph: (219) 464-1234 |
News Archive
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
PANDORA Org and other patient organizations say a recent report from the U.S. Food and Drug Administration (FDA) shows the agency must take further action to open up opportunities for ME/CFS drug development.
General Electric Co. (GE), through its healthcare IT business, and Microsoft Corp. today announced several developments for their planned 50-50 joint venture, including the intention to demonstrate future product capabilities at HIMSS12, the year's largest healthcare IT trade show, later this month.
Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.
Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services using Alvetex technology.
› Verified 6 days ago